Clinical management of squamous cell carcinoma of the oropharynx: How does this differ for HPV-related tumors?

Future Oncology

Volumn 9, Issue 10, 2013, Pages 1413-1416

  Pytynia, Kristen B ^a   Dahlstrom, Kristina R ^a   Sturgis, Erich M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

clinical trial; human papillomavirus; oropharyngeal cancer; treatment

Indexed keywords

ALCOHOL; CAPSID PROTEIN; CETUXIMAB; CISPLATIN; DNA; VIRUS DNA; WART VIRUS VACCINE;

CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; DNA INTEGRATION; DRUG DOSE REDUCTION; EPIDEMIC; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOHISTOCHEMISTRY; INCIDENCE; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS CELL CARCINOMA; STAINING; TOBACCO; VACCINATION; WART VIRUS;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS AS TOPIC; HUMANS; MOUTH NEOPLASMS; OROPHARYNX; OUTCOME ASSESSMENT (HEALTH CARE); PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS;

EID: 84885664965     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.13.121     Document Type: Review

References (25)

1. Mehta V, Yu GP, Schantz SP. Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics. Laryngoscope 120, 2203-2212 (2010
2. Sturgis EM, Cinciripini PM. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer 110, 1429-1435 (2007 (Pubitemid 47463055)
3. Chaturvedi AK, Engels EA, Pfeiffer RM et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29, 4294-4301 (2011
4. Mork J, Lie AK, Glattre E et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 344, 1125-1131 (2001 (Pubitemid 32285233)
5. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl Cancer Inst. Med. 92, 709-720 (2000 (Pubitemid 30365531)
6. Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24-35 (2010
7. Hariri S, Unger ER, Sternberg M et al. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006. J. Infect. Dis. 204, 566-573 (2011
8. Giuliano AR, Lazcano-Ponce E, Villa LL et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol. Biomarkers Prev. 17, 2036-2043 (2008
9. Sturgis EM, Ang KK. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J. Natl Compr. Canc. Netw. 9, 665-673 (2011
10. Dahlstrom KR, Li G, Tortolero-Luna G, Wei Q, Sturgis EM. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck 33, 847-855 (2011
11. Hong AM, Martin A, Chatfield M et al. Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma. Int. J. Cancer 132(12), 2748-2754 (2012
12. Gillison ML, D'Souza G, Westra W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J. Natl Cancer Inst. Med. 100, 407-420 (2008 (Pubitemid 351480511)
13. D'Souza G, Kreimer AR, Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356, 1944-1956 (2007 (Pubitemid 46740304)
14. O'Sullivan B, Huang SH, Perez-Ordonez B et al. Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother. Oncol. 103, 49-56 (2012
15. Baxi SS, Shuman AG, Corner GW et al. Sharing a diagnosis of HPV-related head and neck cancer: the emotions, the confusion, and what patients want to know. Head Neck doi:10.1002/hed.23182 (Epub ahead of print) (2012
16. Chu A, Genden E, Posner M, Sikora A. A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide. Oncologist 18, 180-189 (2013
17. Ang KK, Sturgis EM. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma. Semin. Radiat. Oncol. 22, 128-142 (2012
18. Pytynia KB, Grant JR, Etzel CJ, Roberts DB, Wei Q, Sturgis EM. Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck. J. Clin. Oncol. 22, 3981-3988 (2004 (Pubitemid 41079881)
19. Fakhry C, Westra WH, Li S et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst. Med. 100, 261-269 (2008 (Pubitemid 351480538)
20. O'Sullivan B, Huang SH, Siu LL et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J. Clin. Oncol. 31, 543-550 (2013
21. Huang SH, Perez-Ordonez B, Weinreb I et al. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral Oncol. 49, 79-85 (2013
22. Huang SH, Perez-Ordonez B, Liu FF et al. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 82, 276-283 (2012
23. Muller S, Khuri FR, Kono SA, Beitler JJ, Shin DM, Saba NF. HPV positive squamous cell carcinoma of the oropharynx. Are we observing an unusual pattern of metastases? Head Neck Pathol. 6, 336-344 (2012
24. Peck BW, Dahlstrom KR, Gan SJ et al. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck 35, 794-799 (2012
25. Jain KS, Sikora AG, Baxi SS, Morris LG. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer. Cancer 119, 1832-1837 (2013).